Skip to main content

Table 4 Pairwise comparison of outcome measures between different study time-points in the intervention group

From: The efficacy of transdiagnostic cognitive behavioral therapy on migraine headache: a pilot, feasibility study

Category

Time-point

Reference time-point

Mean Difference

Standard Error

P-value

95% Confidence Interval for Difference

Visual analog scale (headache severity)

1

2

1.875

0.340

 < 0.001

(1.150, 2.600)

3

2.500

0.342

 < 0.001

(1.772, 3.228)

2

3

0.625

0.352

0.096

(-0.125, 1.375)

Migraine disability assessment scale (MIDAS)

1

2

21.875

4.513

 < 0.001

(12.256, 31.494)

3

23.813

4.841

 < 0.001

(13.494, 34.131)

2

3

1.938

0.692

0.013

(0.462, 3.413)

MIDAS-A

1

2

16.938

3.269

 < 0.001

(9.970, 23.905)

3

19.563

3.217

 < 0.001

(12.705, 26.420)

2

3

2.625

1.197

0.044

(0.074, 5.176)

MIDAS-B

1

2

1.594

0.369

0.001

(0.808, 2.379)

3

2.063

0.413

 < 0.001

(1.182, 2.943)

2

3

0.469

0.314

0.157

(-0.202, 1.139)

Headache impact test (HIT)

1

2

6.750

1.493

 < 0.001

(3.568, 9.932)

3

10.313

1.128

 < 0.001

(7.908, 12.717)

2

3

3.563

1.151

0.007

(1.109, 6.016)

Hospital anxiety and depression scale-Anxiety

1

2

2.625

0.774

0.004

(0.975, 4.275)

3

3.688

0.762

 < 0.001

(2.063, 5.312)

2

3

1.063

0.403

0.019

(0.204, 1.921)

Hospital anxiety and depression scale-Depression

1

2

2.063

0.433

 < 0.001

(1.140, 2.985)

3

2.313

0.561

0.001

(1.118, 3.507)

2

3

0.250

0.487

0.615

(-0.789, 1.289)

Days with headache within the past 30 days

1

2

5.625

1.179

 < 0.001

(3.111, 8.139)

3

8.125

1.541

 < 0.001

(4.841, 11.409)

2

3

2.500

1.114

0.040

(0.125, 4.875)

Number of pain-relievers taken during the past 30 days

1

2

7.188

1.085

 < 0.001

(4.875, 9.500)

3

8.688

1.413

 < 0.001

(5.675, 11.700)

2

3

1.500

0.764

0.068

(-0.128, 3.128)

  1. Results based on estimated marginal means